Literature DB >> 7945894

Chemistry of Amadori rearrangement products: analysis, synthesis, kinetics, reactions, and spectroscopic properties.

V A Yaylayan1, A Huyghues-Despointes.   

Abstract

The chemistry of the key intermediate in the Maillard reaction, the Amadori rearrangements product, is reviewed covering the areas of synthesis, chromatographic analyses, chemical and spectroscopic methods of characterization, reactions, and kinetics. Synthetic strategies involving free and protected sugars are described in detail with specific synthetic procedures. GC- and HPLC-based separations of Amadori products are discussed in relation to the type of columns employed and methods of detection. Applications of infrared (IR) and nuclear magnetic resonance (NMR) spectroscopy for structural elucidation of Amadori products are also reviewed. In addition, mass spectrometry of free, protected, and protein-bound Amadori products under different ionization conditions are presented. The mechanism of acid/base catalyzed thermal degradation reactions of Amadori compounds, as well as their kinetics of formation, are critically evaluated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945894     DOI: 10.1080/10408399409527667

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  24 in total

1.  A previously undescribed chemical link between smoking and metabolic disease.

Authors:  Tobin J Dickerson; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

2.  Microspherules from sugars in the absence of nitrogen.

Authors:  Danielle Rand; Marina Belenky; Judith Herzfeld
Journal:  Orig Life Evol Biosph       Date:  2010-06-19       Impact factor: 1.950

3.  Assessment of feasibility of maillard reaction between baclofen and lactose by liquid chromatography and tandem mass spectrometry, application to pre formulation studies.

Authors:  Farnaz Monajjemzadeh; Davoud Hassanzadeh; Hadi Valizadeh; Mohammad R Siahi-Shadbad; Javid Shahbazi Mojarrad; Thomas Robertson; Michael S Roberts
Journal:  AAPS PharmSciTech       Date:  2009-05-20       Impact factor: 3.246

4.  Furosine induces DNA damage and cell death in selected human cell lines: a strong toxicant to kidney Hek-293 cells.

Authors:  Yasmeen Saeed; J Q Wang; N Zheng
Journal:  Food Sci Biotechnol       Date:  2017-08-30       Impact factor: 2.391

5.  Structure-based design of guanosine analogue inhibitors targeting GTP cyclohydrolase IB towards a new class of antibiotics.

Authors:  George N Samaan; Naduni Paranagama; Ayesha Haque; David A Hecht; Manal A Swairjo; Byron W Purse
Journal:  Bioorg Med Chem Lett       Date:  2019-11-12       Impact factor: 2.823

6.  Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats.

Authors:  Olaf Brouwers; Petra M Niessen; Isabel Ferreira; Toshio Miyata; Peter G Scheffer; Tom Teerlink; Patrick Schrauwen; Michael Brownlee; Coen D Stehouwer; Casper G Schalkwijk
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

7.  Synthesis of hexose-related imidazolidinones: novel glycation products in the Maillard reaction.

Authors:  S Horvat; M Roscić; J Horvat
Journal:  Glycoconj J       Date:  1999-08       Impact factor: 2.916

8.  Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation.

Authors:  Nadeem A Ansari; Debabrata Dash
Journal:  Aging Dis       Date:  2012-12-10       Impact factor: 6.745

9.  Detection of Circulating Auto-Antibodies Against Ribosylated-LDL in Diabetes Patients.

Authors:  Firoz Akhter; M Salman Khan; Mohammad Faisal; Abdulrahman A Alatar; Saheem Ahmad
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

10.  Influence of glycation on cis/trans isomerization and tautomerization in novel morphiceptin-related Amadori compounds.

Authors:  I Zigrović; J Kidric; S Horvat
Journal:  Glycoconj J       Date:  1998-06       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.